My guess is that Maxim will be a joint book-running manager of the next financing, same as last year... perhaps another Private Placement, co-brokered with Roth.
Friday, 13 Jun 2014 09:30am EDT
BrainStorm Cell Therapeutics Inc:Enters into definitive agreements with a group of investors, including several healthcare-focused funds, in connection with a private placement of common stock and warrants to purchase common stock.Upon the closing of this financing, BrainStorm will receive gross proceeds of $10.5 million, resulting from the issuance and sale of 42.0 million shares of common stock at a price per share of $0.25, a 15 pct discount to the 30 day volume-weighted average price of $0.294.
News 
Market Data 
Discover 
AI
